Sondaggio utilizzo integratori alimentari

HylobatesConsultingIl team di Hylobates Consulting sta conducendo un’indagine volta a valutare l’andamento globale del mercato degli integratori alimentari in ambito sportivo.

I dati sugli utilizzi e sul mercato degli integratori alimentari per sportivi, compreso il commercio via Internet, sono scarsi. La mancanza di dati impedisce un miglioramento del settore, sia a livello di qualità, che di sicurezza e convenienza, e la sua apertura. Questa indagine è effettuata da Hylobates Consulting srl al fine di comprendere meglio questo mercato.

Ulteriori informazioni possono essere richieste via mail hylobates@hylobates.it. o telefonicamente allo 06 98939628. Ti invitiamo a rispondere a queste poche domande con attenzione per contribuire ad un miglioramento del settore.

Di seguito il link al sondaggio:

http://www.surveymonkey.com/s/B2SKVDH

– Hylo’s Consulting team –

Advertisements

World’s biggest study of food allergies gets underway

7_Allergy_FoodsHylobates is one of the SME participants of the world’s biggest ever study of allergies known as the Integrated Approaches to Food Allergen and Allergy Risk Management (iFAAM) which officially got underway on 19 March. The €9million project spearheaded by the University of Manchester builds on an earlier €14.3 million research study and will involve the worlds leading experts in the UK, Europe, Australia and US. The parting point is the lack of evidence to either prevent food allergy developing or protect adequately those who are already allergic. The 38 partners iFAAM consortium will produce a standardised management process for food manufacturing companies and will also develop tools designed to enforce these regulations and produce evidence-based knowledge to inform new health advice on nutrition for pregnant women, babies and allergy sufferers.

Up to 20 million European citizens suffer from food allergy which may be triggered by a list of foods including milk, egg, peanuts, soya, wheat, tree nuts, mustard, lupin, fish, crustacean and molluscan shell fish and celery which have to be labelled irrespective of the level at which they are included in a recipe. However, management of food allergens that accidently find their way into foods which might otherwise be free of allergen, for example through the use of common processing equipment, remains problematic and often gives rise to precautionary “may contain” labels.

Professor Clare Mills, from the Allergy and Respiratory Centre of The University of Manchester’s Institute of Inflammation and Repair and based in the Manchester Institute of Biotechnology, will head the study. Professor Mills said: “This is a massive research project which will have far reaching consequences for consumers and food producers. The evidence base and tools that result from this will support more transparent precautionary “may contain” labelling of allergens in foods which will make life easier for allergy sufferers as they try to avoid problem foods.”

Sue Hattersley, Head of the UK Food Standard’s Agency’s Allergy Branch said: “We anticipate that the information learned through iFAAM will help determine a more consistent approach to providing consumers with information, so they can make safe choices about the food they eat. Furthermore it will provide a greater insight into the development of food allergies. From an industry and regulatory perspective, it is expected that the results of the project will provide more guidance on the management of food allergens.”

New risk models will be built on pre-existing clinical data sets to support management of these allergens in a factory environment to minimise the use of such labels. Luca Bucchini, manager director of iFAAM partner Hylobates Consulting which will contribute to contamination modelling and in disseminating risk analysis methods to food industry and SMEs, said: “Managing food allergens is still a challenge for many food businesses, particularly smaller SMEs.  Better tools can benefit consumers with food allergies, including children.”

Other researchers will look at tools to measure allergens in food to allow validation and monitoring of allergen management plans. Other strands of the three year project will seek to predict who is likely to suffer a severe reaction, identify whether early introduction of allergenic foods and other nutritional factors may be protective against development of allergies later on in life.


Hylo’s Research Team

PlantLIBRA present in University of Buenos Aires’ 14th International Congress of Internal Medicine

“Knowing the benefits, but also the adverse effects of dietary supplements is very important, explained PlantLIBRA project coordinator Prof Patrizia Restani last August 16th as she presented PlantLIBRA in the 14th International Congress of Internal Medicine, a major event in this specialty, in Buenos Aires, Argentina, and organized by PlantLIBRA partner Hospital and Clinics “José de San Martín” of the University of Buenos Aires (UBA). “The idea is not to cause alarm in the population, but to study plant food supplements and communicate if there are potential drug interactions or risk factors to the people who use them”, she added during her presentation. An additional problem was also posed by Prof. Dr. Roberto Iermoli, director of Teaching and Research Hospital and Clinics at UBA, who said that it is common for patients not to mention or deny to their doctor that they consume these products. “When completing the medical history, the doctor has to ask if the patient is using any substance, and the patient should report if they are taking any dietary supplement.” Moreover, in Argentina, only half of the ten dietary supplements of plant origin most consumed would have few reliable studies to convince a good family doctor, wrote Fabiola Czubaj reporting on the conference for the online presence of the newspaper La Nación.

Dr. Raul Pastor, Head of the Section Polyphenols, Wine and Health of the department of internal medicine of the UBA who studies the cardiovascular risks and benefits of supplements and explained the studies on benefits studied by health area by WP2 partners. He stressed as well the importance of effective communication and believes that the project is critical to improve the reference information for regulating the production, manufacturing, and marketing of dietary supplements based on botanicals. “The current situation is critical, with products that are offered and sold through informal channels such as the internet, with misleading advertisements and even toxic content” he continued.

Product quality is also key. So, experts agreed that not even grapefruit juice should be underestimated. “No plant is the problem, but the content of the product and the person has risk factors,” summed up Prof Restani.

The conference titled ”The PlantLIBRA project- Dietary supplements in human health” was organised by PlantLIBRA’s dissemination partners in cooperation with Hylobates Consulting, partner in charge of project management.

The complete article in Spanish tittled “Mitos y riesgos de los suplementos dietarios” can be found by clicking the link http://www.lanacion.com.ar/1500030-mitos-y-riesgos-de-los-suplementos-dietarios

– PlantLIBRA Management Team –

BRAMA Kick-off meeting

BRAMA  (contract no.12/2337)

Rome, 20-21 July 2012

The new 4 year project BRAMA- Botanicals Risk Assessment training in the Mediterranean Area, meet last Friday 21st of July in the center of Rome to have their kick-off meeting. The project composed of four organizations from Mediterranean countries will promote the mobility and exchanges of knowledge in the field of plant food supplements (PFS) through the training and professionalism of young people.

The project is a Cross-Border Cooperation (CBC) within the European Neighbourhood and Partnership Instrument (ENPI) Mediterranean Sea Basin Joint Operational Programme.Project manager Dr Luca Bucchini  of Hylobates Consulting Sr in Rome, Italy, welcomed partners and ENPI CBC MED officers, and emphasized the core goal of BRAMA which is to build up the competences and professional skills of young researchers, technicians and inspectors in the field of botanicals.

Partners had the chance to present their institution, their experience in the botanical field, and their role in the project. Partners had the chance to present their institution, their experience in the botanical field, and their role in the project. Hylobates Consulting Srl in Rome, Italy, will be conducting the project management and developing the courses and training in quality control and safety assessment of botanicals for both technicians of SME’s and inspectors of regulating authorities. Dr Hanem M. Awad of the National Research Centre (NRC) of Egypt, will be training two selected PhD students on state-of-the-art and novel methods in risk assessment practice of compounds with toxicological activity that can be present in botanicals. Within its modern technical and analytical laboratory facilities, Jordan partner       Alà Al-Subeihi of Aqaba International Laboratories – BEN HAYYAN will train students in applied research for developing physiologically based kinetic (PBK) models for bioactivation and detoxification of selected substances found in PFS. Added to this Mediterranean mix, Prof Anastassios Troganis, University of Ioannina in Greece, brings analytical chemistry research in the project for the comprehensive phytochemical analysis of botanicals, the chemical structure elucidation of compounds of interest, and the development of methods using NMR spectroscopy.

Besides  of training PhD students, BRAMA will train young technicians in quality assurance and safety assessment of botanicals for industry, particularly seeing to the needs of Small and Medium Enterprises. The young  professional counterpart are the inspectors and competent authority staff that will also be trained within modules specifically designed and structured

In addition, ENPI CBC MED officers explained the ENPI programme structure and objectives,  and guided the BRAMA partners with their questions of the financial aspects and rules for the effective implementation of the project.

In the last day of the meeting, project associate Dr Jacques Vervoort of Wagenigen University (NL), remarked that “we need to improve the capacities of young people. That is what BRAMA is about” as he explained the needs for the specialized PhD training courses to be prepared by the partners.

“The project BRAMA is implemented under the ENPI CBC Mediterranean Sea Basin Programme (www.enpicbcmed.eu), and is financed, for an amount of 1,53 million Euro, by the European Union through the European Neighbourhood and Partnership Instrument.

“The 2007-2013 ENPI CBC Mediterranean Sea Basin Programme is a multilateral Cross-Border Cooperation initiative funded by the European Neighbourhood and Partnership Instrument (ENPI). The Programme objective is to promote the sustainable and harmonious cooperation process at the Mediterranean Basin level by dealing with the common challenges and enhancing its endogenous potential. It finances cooperation projects as a contribution to the economic, social, environmental and cultural development of the Mediterranean region. The following 14 countries participate in the Programme: Cyprus, Egypt, France, Greece, Israel, Italy, Jordan, Lebanon, Malta, Palestinian Authority, Portugal, Spain, Syria, Tunisia. The Joint Managing Authority (JMA) is the Autonomous Region of Sardinia (Italy). Official Programme languages are Arabic, English and French.”

– BRAMA Project Management Team –

Caffeine and sport: recent studies

New interesting evidence related to the involvement of caffeine in sport performance has been published during the last month.

The first of these studies suggests that 6 mg/kg BW caffeine supplementation improves by ~2% rowing (2000 m effort)
performance; combination with sodium bicarbonate seems to prevent performance enhancement, due tu GI side effects.
Further investigation to minimize GI symptoms is required. Health claims on caffeine have received favorable opinions by EFSA but have caused concerns with Member States.
The second one reports that adding 8 mg/kg BM caffeine to postexercise carbohydrate (CHO) feedings seems to improve subsequent high-intensity interval-running capacity compared with CHO alone. This effect may be related to higher rates of postexercise muscle glycogen resynthesis previously observed under similar feeding conditions. In line with EFSA health claim assessment (still controversial with Member States) it may be interesting to suggest on label to take
caffeine supplements after the intake of CHO, or with CHO. Nevertheless the recommended dosage in the study seems to be too high (560 mg/day for a 70 kg person).

In both studies a potential concern seems to be related to the levels of caffeine used. For example EFSA, in its opinions, takes into
account lower levels of caffeine compared to those used in trials; Member States allow lower amounts of caffeine in food supplements (Belgium bans solid caffeine). In Italy, for example, no more than 300 mg/day caffeine are informally allowed.

These studies provide further support to the use of caffeine in sports under some circumstances, although levels may be an issue.


Armando Antonelli – Sport Nutrition Team

Food Colorings maximum levels are going to change

Commission Regulation (EU) 232/2012 (link) establishes new maximum levels for some food colorings, amending the Annex II to Regulation (EC) No 1333/2008. These changes will involve the following dyes: Quinoline Yellow (E 104), Sunset Yellow FCF/ Orange Yellow S (E 110) and Ponceau 4R, Cochineal Red A (E 124). The  Regulation will apply from 1 June 2013, but food containing these 3 colorings that have been lawfully placed on the market before 1 June 2013 but that do not comply with the provisions of this Regulation, may continue to be marketed until stocks are exhausted.

The reductions in maximum levels mirror the reduced Acceptable Daily Intake (ADI) levels set by EFSA.. and are quite significant.

Several food products are affected. Regarding food supplements the new maximum levels are listed below:

FS supplied in a solid form

E104 from 300 mg/kg to 35 mg/kg
E110 from 300 mg/kg to 10 mg/kg
E124 from 300 mg/kg to 35 mg/kg

FS supplied in a liquid form

E104 from 100 mg/kg to 10 mg/kg
E110 from 100 mg/kg to 10 mg/kg
E124 from 100 mg/kg to 10 mg/kg

FS supplied in a syrup-type or chewable form

Maximum level for all of them is 10 mg/kg (previously not established).

Food businesses should be aware of the changes, and ensure their suppliers are also reformulating in line with the new specifications. It should be noted that in the United States the maximum levels for E110 are not affected (it can be used according to GMPs); E104 and E124 are not permitted in the United States.
– Sport Nutrition Team –


ASA Adjudication on Leaf Italia SRL

Leaf Italia, maker of Sperlari, Dietorelle, Dietor, Pringles, as well as other brands, was not found in breach of UK advertising regulations (which are similar to those found across the EU) by the ASA. The use of an online game with fruit had been questioned as it suggested that eating Leaf’s candies was equivalent to eating fruit.

Leaf said the purpose of the game was to encourage children to eat fruit, but ASA found that this was unclear. Yet, because individuals exposed to the ads are old enough to differentiate flavored candies from fruit, and would understand the “landmarks” were the flavors of the candies, not actual fruit, and would not imply that the candies had nutritional benefits, ASA decided that the ad ” was unlikely to give a misleading impression of the nutritional and health benefits of the product”.

In our view, it should be noted that ASA has not hesitated to investigate the ads of a business which has its office elsewhere in the EU. On the other hand, ASA seems not to have taken a hard line over online games which are increasingly common, and link a brand of food which is not necessarily in line with recommended nutrient profiles with healthy nutrition. At the same time, as a note of caution, it should be noted that the explanations of Leaf were largely rejected.

Therefore attention is recommended, as other authorities across the EU may take a different stand.

– Luca Bucchini, Hylo’s managing director

%d bloggers like this: